of providing optimal patient care with limited funds. Drug products and related costs represent a considerable portion of institutional expenditures. Since antimicrobial agents commonly consume 20 to 40% of a hospital drug budget, they are frequently the focus of cost-containment efforts.
At The Toronto Hospital. several strategies are currently employed by the antibiotic subcommittee to promote the cost-effective use of antimicrobials, including the following: the maintenance of a controlled formulary system of selected antimicrobials, guidelines for the use of specific antimicrobials and restriction of antimicrobials to specific prescribers or disease states. During 1994 the dosage interval and dose of selected antimicrobials was extended or modified based on a review of relevant literature. including appropriate pharmacokinetic and pharmacodynarnic studies. As a result, changes were made for dosing recommendations for cefotaxime, piperacillin and aminoglycosides. All guidelines and recommendations are published yearly in a handbook distributed to all prescribing physicians.
To complement the efforts of the antibiotic subcommittee in the promotion of appropriate use of antimicrobials, a formal route conversion program was piloted and implemented in the spring of 1994 as part of a pharmacy residency project. The program consisted of written guidelines for route conversion based on disease states and antimicrobial agents, a facts sheet ouUining the benefits of oral therapy and an education program for pharmacists and prescribing physicians. The guidelines included patient selection criteria for route conversion and identification of patient populations in whom oral therapy would not be suitable. Appropriate oral alternatives to formulary injectables was also provided.
A pre-program audit of 27 patients (28 infections) indicated that 79 (41 % ) days of intravenous therapy could have been substituted with oral therapy had the conversion criteria been applied. The same population was audited several weeks post-program implementation. The results of the post-program audit indicated that 49 (26%) days of int.ravenous therapy could have been substituted with oral therapy. This represented a 36% reduction in days of intravenous therapy.
Based on the above findings it was estimated that. potential savings of approximately $400,000 could be attained with hospital-wide implementation of the program.
The formal plan for antimicrobial therapy route conversion was presented to the pharmacy and therapeutics committee. It subsequent.ly received endorsement from the medical advisory committee and hospital administration. The plan included the reduction in total antimicrobial expenditure as well as the addition of one full time pharmacist. to coordinate and facilitate the program for all 1100 plus beds. Because of a manual tracking system and the large size of lhe institution it. was not. difficult. to convince anyone of the value of obtaining 1.he resources required to coordinate this program. Our pharmacists were already performing 1.he function but additional savings could be realized if the program were more formal and aggressive.
Once a pproved, 1.he dollars were removed from the drug budget. Since expenses are allocated to 1.he encl user, each nursing unit.'s antimicrobial budget. was reviewed. Areas such as 1.he operating room, emergency, labour and delivery and psychiatry did not have a reduction to their drug budget. for obvious reasons. Areas with high intravenous antimicrobial use had their budgets reduced accordingly.
A job description for a pharmacoeconomist was formulated and a person with an advanced degree was hired. The drug b u dget is continually monitored against the actual expense. Through six months of this fiscal year lhe targets have been met and we are currently almost $20,000 under budget for antibiolic costs. Although nol all the savings can be attributed lo the route conversion program a significant proportion of the savings is thought to be as a result of lhe route conversion program.
